NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/16/2024
Back to search
Official data from USPTO
LIXI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
44
Latest update
04/16/2024
Trademark type
Combined
Nice classes
5
Filing date
03/29/2021
Registration date
04/16/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/16/2024
Last transaction
04/16/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/01/2020
First use in commerce
12/01/2020
Drawing code
3
Owner type
03
Owner location
BREA, CA
Examiner
WOOD, CAROLINE
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word LIXI with a half circle underneath.
Holders and representatives
Holders
MEBORIUM INC.
MEBO LIFE SCIENCE INC.
Representatives
Farah P. Bhatti Buchalter, A Professional Corporation
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Dietary and nutritional supplements
Publications
History of USPTO decisions and trademark events.
44 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/16/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/12/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/09/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/05/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/03/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/31/2024
IUAF
USE AMENDMENT FILED
01/12/2024
EISU
TEAS STATEMENT OF USE RECEIVED
01/12/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/05/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/10/2023
PUBO
PUBLISHED FOR OPPOSITION
10/10/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/20/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/07/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/09/2023
ALIE
ASSIGNED TO LIE
08/09/2023
NREV
NOTICE OF REVIVAL - E-MAILED
08/08/2023
PGRR
PETITION GRANTED - RESPONSE RECEIVED
08/08/2023
APET
ASSIGNED TO PETITION STAFF
08/07/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/03/2023
PROA
TEAS PETITION TO REVIVE RECEIVED
07/03/2023
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
03/14/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
03/14/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
12/22/2022
GNFR
FINAL REFUSAL E-MAILED
12/22/2022
CNFR
FINAL REFUSAL WRITTEN
12/22/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
11/23/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
04/14/2022
GNSL
LETTER OF SUSPENSION E-MAILED
04/14/2022
CNSL
SUSPENSION LETTER WRITTEN
04/14/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/18/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/17/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/17/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/11/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/11/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/11/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/16/2021
GNRT
NON-FINAL ACTION E-MAILED
11/16/2021
CNRT
NON-FINAL ACTION WRITTEN
11/16/2021
DOCK
ASSIGNED TO EXAMINER
11/08/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/06/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/04/2021
NWAP
NEW APPLICATION ENTERED
04/01/2021
Continuous trademark protection
Get notified about every new filing that threatens LIXI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.